成人尸体供肝移植围术期液体管理与结局:系统综述及专家小组推荐
本文为系统综述及国际专家小组基于GRADE方法制定的推荐,检索Ovid MEDLINE、Embase、Scopus、Google Scholar和Cochrane Central,1624篇筛查研究中18篇纳入最终定量合成(6项单中心RCT、11项单中心观察性研究、1项比较不同液体管理技术的观察性研究)。因干预与结局定义异质,推荐主要基于专家意见及其他临床领域证据。推荐中度限制性或「仅替代」液体方案,尤其 dissection 期;应避免持续高容量;MAP维持>60-65 mmHg;不推荐常规优先使用特定胶体或晶体;反对使用130/0.4羟乙基淀粉。
要点
- 推荐中度限制性或「仅替代」液体方案,尤其移植 dissection 期(证据质量中等,推荐强度弱)。
- 应避免持续高容量,依据无液体反应性、充盈压升高和/或超声心动图发现判断(证据质量中等,推荐强度强)。
- 所有病例MAP应维持>60-65 mmHg(证据质量低,推荐强度强)。
- 证据不足以支持常规容量替代优先选用特定胶体或晶体。
- 推荐反对使用130/0.4羟乙基淀粉,因该人群AKI发生率高。
适用人群与场景
- 成人尸体供肝移植受者,围术期(术中及术后)液体管理。
处置流程与药物剂量
- 推荐中度限制性或「仅替代」液体方案,尤其移植手术 dissection 期(证据质量中等,推荐强度弱)。
- 应避免持续高容量,依据无液体反应性、充盈压升高和/或超声心动图发现判断(证据质量中等,推荐强度强)。
- 所有病例MAP应维持>60-65 mmHg(证据质量低,推荐强度强)。
- 证据不足以支持该人群常规容量替代优先选用特定胶体或晶体。
- 推荐反对使用130/0.4羟乙基淀粉,因该人群AKI发生率高。
研究设计与关键结果
- 系统综述遵循PRISMA指南,采用GRADE方法,由国际专家小组制定推荐;PROSPERO注册号CRD42021241392。
- 共筛查1624项研究,18项符合纳入标准进入最终定量合成:6项单中心RCT、11项单中心观察性研究、1项比较不同液体管理技术的观察性研究。
- 各研究间干预与结局定义存在差异,推荐主要基于专家意见及其他临床领域证据。
证据类型、等级与局限
- 证据类型:系统综述及国际专家小组推荐,采用GRADE方法。
- 推荐强度:限制性液体方案为弱推荐(证据质量中等);避免高容量为强推荐(证据质量中等);MAP维持>60-65 mmHg为强推荐(证据质量低)。
- 局限:各研究间干预与结局定义存在差异;该人群证据不足以支持优先选用特定胶体或晶体。
对床旁实践的改变
- 围术期采用中度限制性或「仅替代」液体方案,尤其 dissection 期(弱推荐,证据质量中等)。
- 通过无液体反应性、充盈压升高和/或超声心动图发现识别并避免持续高容量(强推荐,证据质量中等)。
- 所有病例维持MAP>60-65 mmHg(强推荐,证据质量低)。
- 不常规优先选用特定胶体或晶体进行容量替代(证据不足)。
- 反对使用130/0.4羟乙基淀粉(因该人群AKI发生率高)。
指南或共识出处
- Perioperative fluid management and outcomes in adult deceased donor liver transplantation - A systematic review of the literature and expert panel recommendations(Clin Transplant)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Fluid management practices during and after liver transplantation vary widely among centers despite better understanding of the pathophysiology of end-stage liver disease and of the effects of commonly used fluids. This reflects a lack of high quality trials in this setting, but also provides a rationale for both systematic review of all relevant studies in liver recipients and evaluation of new evidence from closely related domains, including hepatology, non-transplant abdominal surgery, and critical care.
OBJECTIVES: To develop evidence-based recommendations for perioperative fluid management to optimize immediate and short-term outcomes following liver transplantation.
DATA SOURCES: Ovid MEDLINE, Embase, Scopus, Google Scholar, and Cochrane Central.
METHODS: Systematic review following PRISMA guidelines and recommendations using the GRADE approach derived from an international expert panel. Studies included those evaluating the following postoperative outcomes: acute kidney injury, respiratory complications, operative blood loss/red cell units required, and intensive care length of stay. PROSPERO protocol ID: CRD42021241392 RESULTS: Following expert panel review, 18 of 1624 screened studies met eligibility criteria for inclusion in the final quantitative synthesis. These included six single center RCTs, 11 single center observational studies, and one observational study comparing centers with different fluid management techniques. Definitions of interventions and outcomes varied between studies. Recommendations are therefore based substantially on expert opinion and evidence from other clinical settings.
CONCLUSIONS: A moderately restrictive or "replacement only" fluid regime is recommended, especially during the dissection phase of the transplant procedure. Sustained hypervolemia, based on absence of fluid responsiveness, elevated filling pressures and/or echocardiographic findings, should be avoided (Quality of Evidence: Moderate | Grade of Recommendation: Weak for restrictive fluid regime. Strong for avoidance of hypervolemia). Mean Arterial Pressure (MAP) should be maintained at >60-65 mmHg in all cases (Quality of Evidence: Low | Grade of Recommendation: Strong). There is insufficient evidence in this population to support preferential use of any specific colloid or crystalloid for routine volume replacement. However, we recommend against the use of 130/.4 HES given the high incidence of AKI in this population.
参考来源
- Morkane CM, Sapisochin G, Mukhtar AM, et al. Perioperative fluid management and outcomes in adult deceased donor liver transplantation - A systematic review of the literature and expert panel recommendations. Clin Transplant. 2022. PMID: 35304919. doi:10.1111/ctr.14651
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。